98%
921
2 minutes
20
Background: High intensity statin therapy is currently recommended for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in patients with severe hyperlipidemia (HLD), defined as low-density lipoprotein cholesterol (LDL-C) of ≥190 mg/dL.
Objective: We investigated rates and dosages of statin use and associated ASCVD outcomes for patients with severe HLD.
Methods: In a large healthcare system network, patients without ASCVD with an LDL-C ≥ 190 mg/dL were identified and stratified further based on American College of Cardiology /American Heart Association 10-year risk score. Statin use was stratified as: guideline directed statin intensity (GDSI) (high intensity statin) or
Results: Out of 282,298 primary prevention patients, a total of 5205 (1.8%) had LDL-C ≥ 190 mg/dL out of whom 3.7% were on GDSI at the index visit. Over a 5-year follow up, 42% of high-risk patients with severe HLD achieved new GDSI initiation. Compared to patients on GDSI, those on no statin therapy were at significantly higher risk of myocardial infarction (MI) (hazard ratio [HR] = 2.36, 95% CI [1.38-4.04]) and stroke/transient ischemic attack (HR = 2.70, 95% CI [1.43-5.09]). Patients on
Conclusion: High intensity statins are underutilized among patients with severe HLD, which is linked to greater risk of ASCVD events.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jacl.2025.06.011 | DOI Listing |
Genet Med Open
July 2025
Faculty of Biology Medicine and Health, University of Manchester, United Kingdom.
Purpose: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder. This study aimed to analyze the genotype distribution of FCS-causing genes in the United Kingdom.
Methods: Data were anonymously collated from 2 genetic testing laboratories providing national genetic diagnosis services for severe hypertriglyceridemia in the United Kingdom.
Cureus
August 2025
Acute Internal Medicine, University Hospitals of North Midland, Royal Stoke University Hospital, Stoke-on-Trent, GBR.
Infective endocarditis is a potentially fatal condition that can present with non-specific symptoms and rare hematologic manifestations, posing significant diagnostic challenges. We report a compelling case of a 67-year-old male with a history of type 2 diabetes, hypertension, and hyperlipidemia who sought medical attention for a five-month history of progressive iron deficiency anemia, accompanied by weight loss, fatigue, and vague constitutional symptoms. Initial extensive workup, including computed tomography of the thorax, abdomen, and pelvis, gastroscopy, colonoscopy, and transthoracic echocardiography, failed to identify an underlying cause.
View Article and Find Full Text PDFJ Glob Health
September 2025
International Ph.D. Program in Biotech and Healthcare Management, College of Management, Taipei Medical University, Taipei, Taiwan.
Background: As the global battle against COVID-19 continues, understanding the factors contributing to severe outcomes remains critical for public health strategies. We aim to identify the determinants significantly influencing severe COVID-19 infection and mortality among the general population in Taiwan.
Methods: We conducted a retrospective cohort study using data extracted from the Taipei Medical University Clinical Research Database from 1 January 2022 to 31 December 2022.
Ann Med Surg (Lond)
September 2025
Department of Gynecology and Obstetrics, Tribhuwan University Teaching Hospital, Kathmandu, Nepal.
Introduction And Importance: Various metabolic and physiologic changes that occur during pregnancy can sometimes lead to severe hypertriglyceridemia during pregnancy. The resultant hypertriglyceridemia may lead to acute pancreatitis in pregnancy, which even being rare poses significant health risks to both the child and the mother.
Presentation Of Case: A 26-year-old female, G4P1L1A2 at 36 weeks and 3 days of gestation, presented with an acute onset of abdominal pain in the epigastric region and multiple episodes of vomiting.
EClinicalMedicine
September 2025
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Background: The substantial burden of cardiovascular diseases highlights the urgent need for cost-effective interventions to mitigate their impact. While existing evidence on the cardioprotective effect of the influenza vaccine comes primarily from populations with cardiovascular comorbidities, these studies remain susceptible to several sources of bias, including immortal time bias and unmeasured confounding. To attenuate these limitations, our study aimed to assess the effect of influenza vaccination on cardiovascular events in an older population in China, utilizing a target trial emulation framework in conjunction with a proximal causal inference (PCI) approach.
View Article and Find Full Text PDF